Can a female hound with mitral valve prolapse and severe mitral regurgitation safely continue her pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can She Continue Pregnancy?

Yes, a woman with mitral valve prolapse and severe mitral regurgitation can generally continue her pregnancy with close monitoring in a tertiary care center, as most patients tolerate pregnancy well even with severe MR, and valve surgery during pregnancy carries prohibitive maternal (up to 9%) and fetal (30-40%) mortality rates. 1

Key Management Principles

Monitoring Requirements

Pregnant patients with severe MR (stages C and D) must be monitored in a tertiary care center with a dedicated Heart Valve Team including cardiologists, surgeons, anesthesiologists, and obstetricians experienced in managing high-risk cardiac patients. 2

Why Pregnancy Can Usually Continue

The physiological changes of pregnancy actually favor MR tolerance:

  • Decreased systemic vascular resistance reduces the regurgitant fraction, partially compensating for increased blood volume and cardiac output 3
  • Most patients with asymptomatic severe MR tolerate pregnancy without evidence of accelerated LV dysfunction 1
  • The prognosis is excellent for MVP unless regurgitation is severe and poorly tolerated 3

Medical Management During Pregnancy

Avoid ACE inhibitors and ARBs - these are contraindicated due to fetal toxicity (renal dysplasia, oligohydramnios, growth retardation, skull ossification disorders, lung hypoplasia, intrauterine death) 2

Use diuretics and nitrates/dihydropyridine calcium channel blockers if heart failure symptoms develop 3

Beta-blockers are reasonable for rate control if needed and tolerated 2

When Surgery Becomes Necessary (Rare)

Valve operation is reasonable ONLY if there are refractory NYHA class IV heart failure symptoms despite medical therapy 2

Valve operations should NOT be performed in the absence of severe intractable HF symptoms - this is a Class III (Harm) recommendation 2, 1

The risks are substantial:

  • Fetal mortality: 30-40%
  • Maternal mortality: up to 9%
  • Safest surgical window: 20-28 weeks gestation if absolutely necessary 1

High-Risk Features to Monitor

Watch for development of:

  • Depressed LV systolic function
  • Pulmonary hypertension (PA systolic pressure >50 mmHg)
  • NYHA class III-IV symptoms

These features increase risk of heart failure and arrhythmias during pregnancy 1, 4

Delivery Planning

Vaginal delivery is preferred in most cases, even in those who experienced transient heart failure during pregnancy 3, 4

Cesarean section should be reserved for obstetric indications 4

Hemodynamic monitoring during delivery is needed only in the severest cases 3

Clinical Context

Research shows that women with MVP generally tolerate pregnancy well 5, 6, 7, 8. Even severe MR is usually well tolerated because the hemodynamic changes favor forward flow 4. The key is distinguishing between patients who can be managed medically (the vast majority) versus the rare patient with refractory class IV symptoms who might require surgical intervention.

The critical pitfall to avoid is performing valve surgery for anything less than refractory NYHA class IV symptoms - the maternal and fetal mortality risks of surgery during pregnancy far exceed the risks of medical management in nearly all cases.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.